aadi
727 posts

aadi
@techbrahh
bro scientist @stanford

ok so this is actually true — orexin is produced in the hypothalamus and plays a part in wakefulness & energy regulation two orexin agonists (marketed for narcolepsy) have completed Phase 2 (Alixorexton) & Phase 3 (Oveporexton) trials & just recently got Breakthrough Therapy Designation & Priority Review, respectively this means Overporexton might be in the market by end of this year and another investigational (ALKS 7290) has finished Phase 1 specifically for ADHD



The Golden Age of Unseriousness x.com/i/broadcasts/1…


This is wild. theaustralian.com.au/business/techn…





This is wild. theaustralian.com.au/business/techn…


please bro just one more ai lab bro. cmon bro we have a unique perspective on ai research. no one else is doing it like us bro. cmon bro we can raise a few billion and worse case is we just get acquihired bro. nothing to lose bro i promise cmon bro just join my ai research lab

ITS FINALLY HERE SHES SO GORGEOUS



RFK just said they're reclassifying 14 peptides from "do not compound" back to legal. This got buried under Iran and Pentagon news. Here's everything you should know: 1. 14 of 19 restricted peptides are coming back to compounding pharmacies 2. This includes BPC-157, Thymosin Alpha-1, CJC, GHK-Cu, and more 3. "Category 1" means your doctor can prescribe them again 4. This does NOT mean they're FDA-approved drugs 5. 5 peptides with weaker safety profiles stay restricted 6. The legal basis: FDA never had a safety signal to justify the ban 7. Timeline: weeks or months, not years Peptides will be the biggest consumer category of 2026.

s in stanford stands for state-of-the-art

Wildlife photographer Sha Lu captures the perfect moment a small animal looks at the camera while being caught by a predator















